Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Interest Expense - Others: 2017-2021

Historic Interest Expense - Others for Abeona Therapeutics (ABEO) over the last 5 years, with Dec 2021 value amounting to $67,000.

  • Abeona Therapeutics' Interest Expense - Others was N/A to $200,000 in Q1 2022 from the same period last year, while for Mar 2022 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $67,000 for FY2021, which is 88.83% down from last year.
  • As of FY2021, Abeona Therapeutics' Interest Expense - Others stood at $67,000, which was down 88.83% from $600,000 recorded in FY2020.
  • Abeona Therapeutics' 5-year Interest Expense - Others high stood at $600,000 for FY2020, and its period low was $8,000 during FY2017.
  • Over the past 3 years, Abeona Therapeutics' median Interest Expense - Others value was $400,000 (recorded in 2019), while the average stood at $355,667.
  • Per our database at Business Quant, Abeona Therapeutics' Interest Expense - Others spiked by 3,536.36% in 2019 and then slumped by 88.83% in 2021.
  • Yearly analysis of 5 years shows Abeona Therapeutics' Interest Expense - Others stood at $8,000 in 2017, then spiked by 37.50% to $11,000 in 2018, then soared by 3,536.36% to $400,000 in 2019, then surged by 50.00% to $600,000 in 2020, then slumped by 88.83% to $67,000 in 2021.